Does centrifugation matter? Centrifugal force and spinning time alter the plasma metabolome. by Lesche, Dorothea et al.
SHORT COMMUNICATION
Does centrifugation matter? Centrifugal force and spinning time
alter the plasma metabolome
Dorothea Lesche1,2 • Roland Geyer1 • Daniel Lienhard1 • Christos T. Nakas1,3 •
Gae¨lle Diserens4,2 • Peter Vermathen4 • Alexander B. Leichtle1
Received: 18 May 2016 / Accepted: 23 August 2016 / Published online: 15 September 2016
 The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract
Background Centrifugation is an indispensable procedure
for plasma sample preparation, but applied conditions can
vary between labs.
Aim Determine whether routinely used plasma centrifu-
gation protocols (15009g 10 min; 30009g 5 min) influ-
ence non-targeted metabolomic analyses.
Methods Nuclear magnetic resonance spectroscopy
(NMR) and High Resolution Mass Spectrometry (HRMS)
data were evaluated with sparse partial least squares dis-
criminant analyses and compared with cell count
measurements.
Results Besides significant differences in platelet count,
we identified substantial alterations in NMR and HRMS
data related to the different centrifugation protocols.
Conclusion Already minor differences in plasma cen-
trifugation can significantly influence metabolomic pat-
terns and potentially bias metabolomics studies.
Keywords Centrifugation  Plasma  Metabolome 
Relative centrifugal force  Spinning time  Preanalytics
1 Introduction
With current technologies, thousands of small molecules
can be obtained from a single biological sample at the same
time (Psychogios et al. 2011; Wishart et al. 2013). Since
obtaining blood samples is minimally invasive and sam-
pling devices are widely available in medical offices and at
hospitals, blood plasma and serum are the most commonly
used sample matrices in human metabolomic studies
(Vuckovic 2012; Guder and Narayanan 2015). Among
other important pre-analytical variables, a potential source
of variation is the preparation of plasma from whole blood
by centrifugation. Protocols are usually highly standardized
within labs, whereas the relative centrifugation force (RCF)
and spinning time can substantially vary between labs and
projects (Suchsland et al. 2014). The World Health Orga-
nization recommends a protocol applying
2000–30009g for at least 15 min to prepare cell-free
plasma (World Health Organization 2002) and it is claimed
that centrifugation force and spinning time could be
reciprocally adjusted (Thomas 2012). Regarding subse-
quent non-targeted metabolomic studies, varying centrifu-
gation conditions may generate considerable bias. As
previously reported, differences in pre-analytical condi-
tions such as sample collection and storage introduce
substantial bias (Leichtle et al. 2013). Different centrifu-
gation protocols influence the amount of platelets remain-
ing in the plasma, potentially altering the biochemical
signature of the samples (Daves et al. 2014). Hence, we
evaluated the difference of the metabolic profile of human
plasma samples introduced by two different standard
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centrifugation protocols routinely used in our coagulation
and clinical chemistry core lab. To address this question,
we applied a comprehensive approach using non-targeted
nuclear magnetic resonance (NMR) spectroscopy and ultra-
high performance liquid chromatography with quadrupole-
time-of-flight mass spectrometry (UPLC-QTOF) tech-
niques. Comparison of the cell count before and after
centrifugation provided insight on the influence of
remaining cells to the sample composition.
2 Materials and methods
2.1 Sample collection and centrifugation
Two EDTA blood samples (S-Monovette 2.7 ml, K3
EDTA; Sarstedt, Nu¨mbrecht, Germany) were collected
from each of ten apparently healthy volunteers using
Safety-Multifly-needles (Sarstedt, Nu¨mbrecht Germany).
Immediately after blood sampling, automated blood cell
count was performed on a Sysmex XN9000 instrument
(Sysmex Suisse, Horgen, Switzerland). Both blood col-
lection tubes of each patient were centrifuged using two
different protocols, either at 15009g for 10 min or at
30009g for 5 min at 20 C, respectively. Automated blood
cell count was repeated after centrifugation in the plasma
supernatant. Two plasma aliquots of each centrifugation
condition were instantly frozen at -80 C in FluidX
external screw cap 525 ll cryovials (FluidX, Wehrheim,
Germany) until sample preparation and analysis.
2.2 NMR analyses
Plasma aliquots (250 ll) were mixed with 300 ll PBS (pH
7.4) and transferred into standard 5 mm NMR tubes. 1H-
NMR experiments were performed on the 20 plasma ali-
quots in randomized order for metabolic profiling.
A Bruker Avance II spectrometer (Bruker, Karlsruhe,
Germany) operating at a resonance frequency of 500 MHz
for 1H and equipped with a 5 mm ATM BBFO probe with
z-gradient was used to acquire the spectra employing a
PROJECT (Periodic Refocusing of J-Evolution by Coher-
ence Transfer) sequence (Aguilar et al. 2012). Each spec-
trum was acquired at 300 K applying 64 transients, a
spectral width of 10 kHz, a data size of 64 K points, an
acquisition time of 3.28 s, and a relaxation delay of 5 s.
The spectra were processed using the Bruker Topspin
software (version 3.1, patch level 6). Processing included
exponential weighting with a line broadening factor of
0.5 Hz, Fourier-transform, and manually phasing. A home-
written Matlab program (using MATLAB R2012a, Math-
works) was used for bucketing and Probabilistic Quotient
Normalization (PQN) of the data.
2.3 UPLC-QTOF analyses
Plasma aliquots were prepared by protein precipitation
using pre-chilled (-20 C) methanol/acetonitrile 1:1 (v/v)
and analyzed in randomized injection order on a QTOF MS
(Synapt G2-Si HDMS, Waters Corp., Milford, USA) cou-
pled with preceding chromatographic separation on an
UPLC Acquity system (Waters) using an Acquity UPLC
HSS T3 C18 column. The mobile phases comprised of
0.1 % formic acid in LC–MS-grade water as well as
methanol containing 0.1 % formic acid. A linear gradient
over 14 min changing from polar to organic phase was
applied (for details see Supplementary Information 1).
2.4 Statistical analysis
Statistical analysis was performed using the ‘‘R’’ software
(version 3.2.3; https://www.R-project.org/) and SIMCA
(version 14, MKS Instruments AB, Malmo, Sweden). Nor-
mality testing for cell count parameters was carried out using
the Anderson–Darling test. To compare the hemograms
before and after centrifugation the paired Wilcoxon signed
rank test with continuity correction was performed. Mul-
tilevel sparse partial least squares discriminant analyses
(sPLS-DA) was used on NMR bucket data (Gonzalez et al.
2011). NMR buckets were assigned to metabolites based on
literature (Liu et al. 1996) as well as on additionally per-
formed 2D NMR measurements (data not shown). Data
generated on the UPLC-MS systems (i.e., raw-files) were
directly imported into Progenesis QI (Nonlinear Dynamics,
Newcastle upon Tyne, UK) for peak picking and run align-
ment. In addition, raw data was converted into mzXML-
format using Proteowizard (Chambers et al. 2012) for pro-
cessing with the ‘xcms’-package for R (https://masspec.
scripps.edu/xcms/download.php) according to previously
published protocols (Patti et al. 2012; Tautenhahn et al.
2008; Smith et al. 2006; Benton et al. 2010). After extraction
of the peak table, an sPLS-DA was performed on the xcms
peak data as well.Metabolic features fromUPLC-QTOFMS
analysis were tentatively assigned using the METLIN data-
base with Dm/z of 0.3 Da (Smith et al. 2005). PCA was
performed using the ‘ropls’ package for R.
3 Results and discussion
Before centrifugation, samples in both protocol groups did not
differ in their apparently normal hemogram results (cf. Sup-
plementary Information, Table 1). After centrifugation,
plasma samples originating from both protocols differed in
thrombocyte count (p = 0.05, median15009g; 10min. =
137.5 G l-1 (IQR 83.0–162.1), median30009g; 5min. = 59.5
G l-1 (IQR 12.6-81.2), cf. Supplementary Information,
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Fig. 2). Already a simple hemogram revealed significant
differences between centrifugation protocols regarding the
residual thrombocyte count, suggesting consequent alter-
ations in the metabolome. According to the literature,
both protocols should yield the same results (centrifugal
force and spinning time reciprocally related by factor 2,
Thomas 2012). As 30009g/50 resulted in lower platelet
counts, we assume that the centrifugal effect of g-force is
overcompensating the effect of the spinning time.
In NMR analysis we could extract a total of 186 spectral
buckets. Principal component analysis (PCA) on these
buckets demonstrated high metabolic reproducibility of
plasma aliquots, i.e. clustering of scores from plasma of the
same subjects (cf. Supplementary Information, Fig. 1a).
However, a subsequent multilevel sPLS discriminant
analysis yielded complete separation of both post-cen-
trifugation groups (Fig. 1). Responsible for this separation
was mainly glutamine, present in 5 of the top 20 buckets
(4 9 lower in group C1 than in group C2, 1 9 higher in
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Fig. 1 sPLS-DA plot of the
individuals of both
centrifugation groups (C1
15009g, 10 min; C2 30009g,
5 min) for the NMR data
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group C1 than in group C2, Metabolomics Standards Ini-
tiative (MSI) level 2 identification), which is actively
metabolized in human platelets as a preferential mito-
chondrial oxidative substrate (Vasta et al. 1995). We
assume that concentration in the sample extract might be
higher in case of more remaining thrombocytes after
centrifugation.
We recorded 20 post-centrifugation spectra using
UPLC-QTOF MS in positive as well as negative ionization
mode, 10 for each centrifugation protocol. The positive
mode spectra were converted to mzXML files to be ana-
lyzed with the ‘xcms’-package for R. After peak alignment,
retention time correction, and peak filling, we extracted a
peak list and performed a multilevel sPLS-DA (Fig. 2) on
the transposed table from xcms. PCA did not reveal sepa-
ration of the centrifugation groups (Supplementary Infor-
mation, Fig. 1b). From the metabolic features of xcms data
analysis responsible for group separation (n = 43,
p\ 0.2), about two-third could be matched to features
extracted by Progenesis QI (retention time and high
C2
C2
C2
C2
C2
C2
C2
C2
C2
C2
C1
C1
C1
C1
C1
C1
C1
C1
C1
C1
PlotIndiv
−3
0
3
−6 −3 0 3 6
X−variate 1
X
−
va
ria
te
 2
Fig. 2 sPLS-DA plot of the
individuals of both
centrifugation groups (C1
15009g, 10 min; C2 30009g,
5 min) for the UPLC-QTOF
data
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resolution MS data matched; data not shown). Search in
METLIN database and putative assignment of identities
revealed mainly lipid species. Responsible for the sPLS-
DA based group separation of the positive mode MS xcms
data were, among others, the peaks with m/z 161.0586 at
RT 0.80 min, m/z 787.6515 at RT 12.52 min and m/z
835.6451 at RT 12.63 min. The latter two compounds
appear to be a sphingomyelin SM(40:1) and the sodium
adduct of a sphingomyelin SM(42:2), respectively,
according to the mass and fragmentation spectra from high
energy scan in positive and negative ionization mode (MSI
level 3 identification). For both, NMR and UPLC Q-TOF
analyses, PCA did not show clustering for age or sex (data
not shown), separating buckets and peaks are displayed as
Supplementary Information, Fig. 3.
Since there is currently no consistent recommendation
regarding centrifugation conditions in metabolomics stud-
ies, selection criteria for spinning conditions represent a
balancing between gentle cell handling and shorter turn-
around time. It is well known that centrifugation conditions
vary between laboratories, but despite the potential influ-
ence on many subsequent analyses, centrifugation condi-
tions are still a neglected ‘‘blind spot’’in otherwise rigid
pre-analytical standardization (Guder and Narayanan 2015;
Brauer et al. 2010; Vuckovic 2012; Yin et al. 2015). In our
laboratory, both centrifugation settings are applied in
clinical routine diagnostics, depending on the requested
analyses (e.g., lower RCF for coagulation samples). We
were able to identify significantly different buckets and
peaks that provide discriminatory power between these two
centrifugation protocols in multilevel sPLS-DA using
NMR as well as UPLC-QTOF MS measurements, respec-
tively. Moreover, in the NMR analyses free glutamine
content seems to be associated with centrifugation condi-
tions. Using non-targeted UPLC-QTOF MS analyses we
primarily identified different lipid classes (i.e., glyc-
erophosphocholines and sphingomyelins) to be affected by
selection of a certain centrifugation protocol. Glutamine is
known to show a high plasma variability due to the active
hydrolysis of glutamine in platelets (Guder et al. 2009),
whereas lipids are affected by the residual cell counts at
lower and increased cell disruption at higher centrifugation
force. Due to the paired study design with two identical
primary samples, a timely standardized pre-analytical
handling of each sample, and the randomized batch-wise
analytical procedures, we may largely exclude additional
sources of bias that might have interfered with the sample
composition. While the fold changes in single metabolites
identified with both strategies are generally low, their
combined effect leads to perfect separation of both groups.
In case of a small biological difference among analysis
groups and use of different centrifugation protocols, these
per se minor changes might substantially contribute to
group separation and lead to biased interpretation.
4 Conclusion
Our study demonstrates that different routinely used cen-
trifugation conditions exert significant effects on the results
of non-targeted metabolomics analyses using NMR and
UPLC-QTOF MS. Therefore it is necessary to carefully
standardize the centrifugation protocols to ensure compa-
rability of samples, especially when it comes to multi-
center studies or long-term sample storage in a biobank. If
centrifugation conditions, for example across study centers,
are not properly reviewed, study results might be consid-
erably biased and irreproducible. Detailed centrifugation
protocols should be a regular part of any publication cov-
ering plasma sample preparation, especially in the field of
metabolomics.
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